STVN — Stevanato Group S.p.A.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1849853 ·
Italy
Last close
$15.25
Market Cap
$759.94M
52W High
$23.92
52W Low
$12.05
ADV30
979,981
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 326,063,000 | 94,958,000 | 60,325,000 | 41,843,000 | 2,667,694,000 | 114,902,000 | 1,073,694,000 |
| Jun 2026 | 302,003,000 | 86,811,000 | 51,282,000 | 22,958,000 | 2,618,744,000 | 78,639,000 | 1,068,905,000 |
| Mar 2026 | 273,600,000 | 75,200,000 | 38,800,000 | 28,000,000 | 2,583,821,000 | 111,670,000 | 1,052,995,000 |
| Dec 2025 | 346,482,000 | 106,899,000 | 70,084,000 | 47,555,000 | 2,543,974,000 | 130,603,000 | 1,057,453,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$259,095,000
Investing CF
$-261,050,000
Financing CF
$689,000
CapEx
$-267,303,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$0.50
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$1,071,651,000
Inventory
$301,554,000
Receivables
$540,696,000
ST Investments
$716,000
EBIT TTM
$208,115,000
Pretax Income TTM
$202,679,000
Interest Exp TTM
$5,436,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,225,227,008
EBITDA
$298,831,008
Free Cash Flow
$-104,701,248
Enterprise Value
$6,074,530,304
Total Cash
$79,142,000
Total Debt
$445,302,016
Shares Out
49,832,201
Trailing EPS
$0.57
Book Value
$6.60
ROE
9.1%
ROA
5.4%
Div Yield
0.29%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,186,282,000 | 198,801,000 | 139,839,000 | 2,543,974,000 | 1,057,453,000 | 1,486,483,000 | 286,077,000 |
| Dec 2024 | 1,104,036,000 | 161,142,000 | 117,778,000 | 2,328,819,000 | 924,434,000 | 1,404,339,000 | 155,776,000 |
| Dec 2023 | 1,085,354,000 | 200,720,000 | 145,631,000 | 2,071,577,000 | 938,931,000 | 1,132,531,000 | 105,210,000 |
| Dec 2022 | 983,680,000 | 192,431,000 | 142,849,000 | 1,659,698,000 | 663,788,000 | 996,130,000 | 103,312,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.85
Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $10.00 · spot: $15.36 · call volume: 19 · put volume: 11
Expected Move to 2027-03-19:
±$3.98
(25.88%) —
implied range
$11.38 –
$19.33
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INMD | InMode Ltd. | $743.47M | $12.92 | — |
| BVS | Bioventus Inc. | $725.83M | $10.60 | — |
| BBNX | Beta Bionics, Inc. | $800.28M | $14.72 | — |
| KIDS | ORTHOPEDIATRICS CORP | $820.13M | $31.41 | — |
| DCTH | DELCATH SYSTEMS, INC. | $673.84M | $19.37 | — |
News headlines (Yahoo Finance, 1h cache)
Here’s What Drove Stevanato Group’s (STVN) Q3 Outperformance
2026-11-18 16:12 · Yahoo
Stevanato Group to Participate in Upcoming Investor Conferences
2026-11-16 13:00 · Yahoo
Broader Biologics Growth Strengthens Stevanato’s (STVN) Long-Term Outlook
2026-11-10 18:47 · Yahoo
Why Stevanato Group Bears Were Right Before The Drop
2026-11-04 22:10 · Yahoo
Stevanato Group (STVN) Faces Legal Investigation Over GLP 1 Disclosure
2026-11-04 12:15 · Yahoo
Stevanato Group (STVN) Could Be 42% Undervalued Following Q3 Earnings
2026-11-04 10:12 · Yahoo
Stevanato Group Q3 Earnings Call Highlights
2026-11-04 09:14 · Yahoo
Stevanato Group S.p.A. Q3 2026 Earnings Call Summary
2026-11-04 03:35 · Yahoo
Stevanato (STVN) Q3 2026 Earnings Call Transcript
2026-11-03 21:17 · Yahoo
Stevanato Group SpA (STVN) (Q3 2026) Earnings Call Highlights: Revenue Climbs 8% as Non-GLP ...
2026-11-03 21:07 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.